US approves Ascendis Pharma’s therapy for hormone disorders
Ascendis Pharma said the US Food and Drug Administration approved its therapy to treat adult patients with a hormone disorder. This sent the drugmaker’s shares up more than 10%.
BELIEBTE BEITRÄGE
Putin may discuss Ukraine peace deal with Trump
November 22, 2024
Spain’s vice-president Ribera blames floods on climate change
November 22, 2024
Storm lashes northwestern US, killing two people
November 22, 2024
Iceland volcano erupts for tenth time in three years
November 22, 2024
LIVEÜBERTRAGUNG